[{"arm_notes": "New Type treatment : bemcentinib", "treatment_id": null, "treatment_name": "bemcentinib", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : N/A", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Zilucoplan", "treatment_id": 1396, "treatment_name": "Zilucoplan", "treatment_type": "Anti-inflammatories", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": null, "treatment_id": null, "treatment_name": "acalabrutinib", "treatment_type": "Kinase inhibitor", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": "Adaptive 2 arms trial (sub-protocols): ACCORD-2-001,Sub-002,-003,-004,-006", "treatment_id": 1396, "treatment_name": "Zilucoplan", "treatment_type": "Anti-inflammatories", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Adaptive 2 arms trial (sub-protocols): ACCORD-2-001,Sub-002,-003,-004,-006", "treatment_id": 191, "treatment_name": "Bemcentinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Adaptive 2 arms trial (sub-protocols): ACCORD-2-001,Sub-002,-003,-004,-006", "treatment_id": 12, "treatment_name": "Acalabrutinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Adaptive 2 arms trial (sub-protocols): ACCORD-2-001,Sub-002,-003,-004,-006", "treatment_id": 776, "treatment_name": "Medi3506", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Adaptive 2 arms trial (sub-protocols): ACCORD-2-001,Sub-002,-003,-004,-006", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "New Type treatment : bemcentinib", "treatment_id": null, "treatment_name": "bemcentinib", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : human immunoglobulin (Ig) G1 monoclonal antibody (mAb)", "treatment_id": null, "treatment_name": "human immunoglobulin (Ig) G1 monoclonal antibody (mAb)", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": null, "treatment_id": null, "treatment_name": "acalabrutinib", "treatment_type": "Kinase inhibitor", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Zilucoplan", "treatment_id": 1396, "treatment_name": "Zilucoplan", "treatment_type": "Anti-inflammatories", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Heparin", "treatment_id": null, "treatment_name": "Heparin", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Refer to IMPD", "treatment_id": null, "treatment_name": "Refer to IMPD", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}]